Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like Argos Cuts Staff by 38% After Devastating Phase III News March 9, 2017 Epinex Diagnostics To Present At The BIO CEO & Investor Conference February 9, 2017 This Booming Biotech Inks Huge Lease in the East Bay May 2, 2017